ALZN
Price
$0.94
Change
+$0.04 (+4.44%)
Updated
Mar 1, 6:59 PM EST
SNSE
Price
$0.85
Change
-$0.00 (-0.00%)
Updated
Mar 1, 6:59 PM EST
66 days until earnings call
Ad is loading...

Compare trend and price ALZN vs SNSE

Header iconALZN vs SNSE Comparison
Open Charts ALZN vs SNSEBanner chart's image
Alzamend Neuro
Price$0.94
Change+$0.04 (+4.44%)
Volume$9.32K
CapitalizationN/A
Sensei Biotherapeutics
Price$0.85
Change-$0.00 (-0.00%)
Volume$43.6K
CapitalizationN/A
View a ticker or compare two or three
ALZN vs SNSE Comparison Chart

Loading...

ALZNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
SNSEDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ALZN vs. SNSE commentary
Mar 02, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALZN is a StrongBuy and SNSE is a Hold.

COMPARISON
Comparison
Mar 02, 2024
Stock price -- (ALZN: $0.94 vs. SNSE: $0.85)
Brand notoriety: ALZN and SNSE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALZN: 30% vs. SNSE: 89%
Market capitalization -- ALZN: $6.06M vs. SNSE: $21.25M
ALZN [@Biotechnology] is valued at $6.06M. SNSE’s [@Biotechnology] market capitalization is $21.25M. The market cap for tickers in the [@Biotechnology] industry ranges from $541.24B to $0. The average market capitalization across the [@Biotechnology] industry is $2.59B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALZN’s FA Score shows that 0 FA rating(s) are green whileSNSE’s FA Score has 1 green FA rating(s).

  • ALZN’s FA Score: 0 green, 5 red.
  • SNSE’s FA Score: 1 green, 4 red.
According to our system of comparison, SNSE is a better buy in the long-term than ALZN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALZN’s TA Score shows that 3 TA indicator(s) are bullish while SNSE’s TA Score has 4 bullish TA indicator(s).

  • ALZN’s TA Score: 3 bullish, 3 bearish.
  • SNSE’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, SNSE is a better buy in the short-term than ALZN.

Price Growth

ALZN (@Biotechnology) experienced а +4.92% price change this week, while SNSE (@Biotechnology) price change was +12.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.02%. For the same industry, the average monthly price growth was +20.20%, and the average quarterly price growth was +48.09%.

Reported Earning Dates

ALZN is expected to report earnings on Jan 03, 2024.

SNSE is expected to report earnings on May 07, 2024.

Industries' Descriptions

@Biotechnology (+7.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ALZN with price predictions.
OPEN
A.I.dvisor published
a Summary for SNSE with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
SNSE($21.2M) has a higher market cap than ALZN($6.06M). SNSE YTD gains are higher at: 22.832 vs. ALZN (5.618). ALZN has higher annual earnings (EBITDA): -15.33M vs. SNSE (-37.64M). SNSE has more cash in the bank: 72M vs. ALZN (1.7M). ALZN has less debt than SNSE: ALZN (345K) vs SNSE (6.77M). ALZN (0) and SNSE (0) have equivalent revenues.
ALZNSNSEALZN / SNSE
Capitalization6.06M21.2M29%
EBITDA-15.33M-37.64M41%
Gain YTD5.61822.83225%
P/E RatioN/AN/A-
Revenue00-
Total Cash1.7M72M2%
Total Debt345K6.77M5%
TECHNICAL ANALYSIS
Technical Analysis
ALZNSNSE
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
70%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
74%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 2 days ago
70%
Declines
ODDS (%)
Bearish Trend 15 days ago
90%
Bearish Trend 15 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
N/A
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
78%
View a ticker or compare two or three
Ad is loading...
ALZNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
SNSEDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COYA9.951.05
+11.80%
Coya Therapeutics
PRAX49.542.96
+6.34%
Praxis Precision Medicines
AOS83.991.09
+1.31%
AO Smith Corp
LIXT2.54-0.03
-1.17%
Lixte Biotechnology Holdings
AGL6.05-0.08
-1.31%
agilon health

ALZN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALZN has been loosely correlated with SNSE. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ALZN jumps, then SNSE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALZN
1D Price
Change %
ALZN100%
+2.61%
SNSE - ALZN
41%
Loosely correlated
N/A
SPRC - ALZN
31%
Poorly correlated
+3.65%
AXON - ALZN
30%
Poorly correlated
+2.26%
MDGL - ALZN
29%
Poorly correlated
+6.71%
AVRO - ALZN
29%
Poorly correlated
N/A
More

SNSE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNSE has been loosely correlated with ALZN. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if SNSE jumps, then ALZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNSE
1D Price
Change %
SNSE100%
N/A
ALZN - SNSE
40%
Loosely correlated
+2.61%
FATE - SNSE
36%
Loosely correlated
+9.40%
SRNEQ - SNSE
36%
Loosely correlated
N/A
GOSS - SNSE
34%
Loosely correlated
-2.82%
ORMP - SNSE
32%
Poorly correlated
+4.27%
More